Zobrazeno 1 - 10
of 154
pro vyhledávání: '"Sujoy, Khan"'
Autor:
Sujoy Khan
Publikováno v:
Indian Dermatology Online Journal, Vol 15, Iss 6, Pp 1055-1055 (2024)
Externí odkaz:
https://doaj.org/article/1f1e4f2070c9467f811b18107dbdadda
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Chronic lymphocytic leukaemia (CLL) is a malignancy of clonally expanded antigen-switched, neoplastic, mature B cells. CLL is characterised by a variable degree of immunosuppression and secondary hypogammaglobulinemia. B-cell depleting therapies have
Externí odkaz:
https://doaj.org/article/32fbe03366384be698cd924edc236c5a
Autor:
Sujoy Khan FRCP, FRCPath, Charu Chopra FRCPath, Alaistair Mitchell MRCP, Alla Nakonechna PhD, Patrick Yong FRCPath, Mohammed Yousuf Karim FRCPath
Publikováno v:
Allergy & Rhinology, Vol 13 (2022)
Background Chronic spontaneous urticaria (CSU) can be extremely debilitating to the patient and challenging for the treating clinician. The National Institute of Health and Clinical Excellence (NICE) in the United Kingdom (UK) recommendation of omali
Externí odkaz:
https://doaj.org/article/0ffdcdae76954aa7a6144e7f6ea0d608
Autor:
Adrian M. Shields, Susan Tadros, Adam Al-Hakim, Jeremy M. Nell, Me Me Nay Lin, Michele Chan, Sarah Goddard, John Dempster, Magdalena Dziadzio, Smita Y. Patel, Shuayb Elkalifa, Aarnoud Huissoon, Christopher J. A. Duncan, Archana Herwadkar, Sujoy Khan, Claire Bethune, Suzanne Elcombe, James Thaventhiran, Paul Klenerman, David M. Lowe, Sinisa Savic, Siobhan O. Burns, Alex G. Richter
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
BackgroundIndividuals with primary and secondary immunodeficiency (PID/SID) were shown to be at risk of poor outcomes during the early stages of the SARS-CoV-2 pandemic. SARS-CoV-2 vaccines demonstrate reduced immunogenicity in these patients.Objecti
Externí odkaz:
https://doaj.org/article/49c785e79b714896b5548d584cac175b
Autor:
Leigh Naylor-Adamson, Anisha R. Chacko, Zoe Booth, Stefano Caserta, Jenna Jarvis, Sujoy Khan, Simon P. Hart, Francisco Rivero, David J. Allsup, Mònica Arman
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Bacterial infections are a major cause of morbidity and mortality in chronic lymphocytic leukemia (CLL), and infection risk increases in patients treated with the Bruton’s tyrosine kinase (Btk) inhibitor, ibrutinib. Btk and related kinases (like Te
Externí odkaz:
https://doaj.org/article/ae5be3bf207c4bf3ac689a97a416281c
Autor:
Deepak P M Rajan, Sujoy Khan
Publikováno v:
Lung India, Vol 39, Iss 4, Pp 382-383 (2022)
Externí odkaz:
https://doaj.org/article/ed7375ca302d43908f6f1d6824fe4c76
Autor:
Sujoy Khan, Rebecca Avison
Publikováno v:
Indian Dermatology Online Journal, Vol 11, Iss 6, Pp 1016-1018 (2020)
Externí odkaz:
https://doaj.org/article/ab4653fedffa4c20bc9586dcb7b75870
Autor:
Sujoy Khan
Publikováno v:
Apollo Medicine, Vol 15, Iss 3, Pp 147-151 (2018)
Background: Bronchial asthma affects over 300 million people worldwide and half of these patients have underlying allergic disease. Accurate identification of allergen triggers will help identify patients that may benefit from immunotherapy. Objectiv
Externí odkaz:
https://doaj.org/article/128d9f80f04544b2ab7ce89a0598912b
Autor:
Shilpa Bhartia, Sujoy Khan
Publikováno v:
European Medical Journal Dermatology, Vol 5, Iss 1, Pp 106-112 (2017)
Schnitzler syndrome is a rare acquired autoinflammatory disorder that is characterised by recurrent fevers, bone or joint pains, urticarial rash, and monoclonal immunoglobulin M paraprotein, while the variant form has immunoglobulin G monoclonal para
Externí odkaz:
https://doaj.org/article/7e3af05a41a844eaa242acda9c6ad399
Autor:
Katie Townsend, Evon Boules, Rachael O’Brien, Sai Murng, Smita Y. Patel, Helen Baxendale, Siraj A. Misbah, Ariharan Anantharachagan, Aarnoud Huissoon, Richard Herriot, Andrew R. Gennery, Kenneth F Baker, David M. Lowe, Lucy Leeman, Suzanne Elcombe, Alex G. Richter, Grant Hayman, Philip D Bright, Moira Thomas, Sarah Goddard, Magdalena Dziadzio, Prashantha M. Vaitla, Sameer Bahal, Betsy Cleave, Dylan James Mac Lochlainn, Elizabeth McDermott, Malini Bhole, Anna Shrimpton, Sujoy Khan, Nisha Verma, William H. Bermingham, Sinisa Savic, Anthony Williams, Gururaj Arumugakani, Lavanya Diwakar, Elizabeth Drewe, James Laffan, Lucy Cliffe, Catherine Stroud, Stephen Jolles, A Herwadkar, Siobhan O. Burns, Adrian M Shields, Shanti Mahabir, Scott Hackett, Sofia Grigoriadou, Sarah Johnston, John Dempster, Hadeil Morsi, Peter Lane, Sadia Noorani, Arthur Price, Tasneem Rahman, Fatima Dhalla, Christopher J A Duncan, Lisa Devlin, Harichandrana Ghanta, Fiona Moghaddas, Charu Chopra, Suranjith Senevirantne, Shuayb Elkhalifa, Rashmi Jain
Publikováno v:
Clinical and Experimental Immunology
Purpose To define the burden of morbidity and mortality arising from COVID-19 in individuals with primary (PID) and secondary immunodeficiency (SID) in the United Kingdom. Methods In March 2020, the United Kingdom Primary Immunodeficiency Network (UK
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0eed5fd7211e9861f9848e16aa90a01f
https://ora.ox.ac.uk/objects/uuid:6db535d9-055a-4275-bc3f-813e98fa7d36
https://ora.ox.ac.uk/objects/uuid:6db535d9-055a-4275-bc3f-813e98fa7d36
